The Veterinary Vaccines (except for Foot and Mouth) market in Greece, valued at 88.865 million USD in 2023, reflects a modest stabilization post several fluctuations. Since 2013, the market endured notable declines especially around 2014 and 2015. Recovery was evident in 2017 and 2018 with positive year-on-year growth, yet it faced another contraction and sluggish growth into the early 2020s. The compounded annual growth rate (CAGR) over the last five years is negative, albeit slight, indicating minimal average shrinkage per annum.

Future trends to watch for include:

The impact of technological advancements in veterinary medicine driving innovation in vaccine development.
Shifts in animal health regulations and policies influencing market dynamics.
Increasing awareness of animal health and welfare potentially heightening demand.
Pandemic-induced fluctuations and economic conditions affecting market performance.